We specifically studied MYCN, MYBL2, BIRC5, BARD1 and AURKA, poor prognosis markers of neuroblastoma, and CCNA2 and CCNE1 genes, involved in general carcinogenesis. The gene discussed is BARD1; the disease is neuroblastoma.